Drug Type Monoclonal antibody |
Synonyms |
Target- |
Mechanism- |
Active Indication |
Inactive Indication- |
Originator Organization Alchemab Therapeutics Ltd.Startup |
Active Organization Alchemab Therapeutics Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Amyotrophic Lateral Sclerosis | Preclinical | GB | Alchemab Therapeutics Ltd.Startup | 22 Jun 2023 |
Frontotemporal Dementia | Preclinical | GB | Alchemab Therapeutics Ltd.Startup | 22 Jun 2023 |